What is Nextstep Robotics?
Nextstep Robotics operates at the intersection of robotics and physical therapy, developing sophisticated hardware designed to restore mobility. Their flagship innovation, the AMBLE device, provides graded, variable assistance during gait training, effectively bridging the gap between clinical necessity and technological capability. By focusing on foot drop and other mobility-limiting conditions, the company provides clinicians with a scalable, affordable tool that enhances patient outcomes through data-driven rehabilitation.
The company's market position is defined by its commitment to clinical efficacy and accessibility. Unlike traditional, high-cost robotic systems, Nextstep Robotics prioritizes the integration of its technology into diverse clinical settings, ensuring that advanced neurorehabilitation is not limited to elite medical centers. This approach aligns with the growing demand for cost-effective, high-impact assistive technology in the global healthcare market.
How much funding has Nextstep Robotics raised?
Nextstep Robotics has raised a total of $500K across 1 funding round:
Unspecified
$500K
Unspecified (2020): $500K with participation from Abell Foundation, Maryland Momentum Fund, and University of Maryland Global Campus
Key Investors in Nextstep Robotics
Abell Foundation
A philanthropic organization focused on enhancing quality of life in Maryland by supporting initiatives that provide opportunity and economic development.
Maryland Momentum Fund
An early-stage investment fund that supports promising technology companies affiliated with the University System of Maryland.
University of Maryland Global Campus
An academic institution that actively participates in the regional innovation ecosystem to foster research and commercialization of new technologies.
What's next for Nextstep Robotics?
With the recent capital backing, Nextstep Robotics is expected to accelerate its product development cycle and broaden its clinical footprint. The strategic roadmap likely includes expanding the deployment of the AMBLE device across rehabilitation centers, further validating its clinical outcomes through ongoing research, and potentially exploring new iterations of its robotic assistance technology. As the company moves into this next phase of growth, the focus will remain on scaling manufacturing capabilities and strengthening its presence in the neurorehabilitation market, ultimately aiming to set a new standard for patient independence and mobility recovery.
See full Nextstep Robotics company page
